Treatment at Infusion Center Beneficial in Sickle Cell Disease
Outcomes significantly better for treatment of vaso-occlusive crises at infusion center versus emergency department
Ticagrelor, Prasugrel Compared in ACS Treated With PCI
Prespecified subgroup analysis of data from a randomized clinical trial suggest that a prasugrel-based strategy is preferable
Two-Dose Novavax Vaccine Protects Against SARS-CoV-2 Infection
Vaccine efficacy in adults was 89.7 percent overall, 86.3 percent against B.1.1.7 (alpha) variant, and 96.4 percent against non-B.1.1.7 variants
Radioligand Therapy Slows Advanced PSMA+ Prostate Cancer
177Lu-PSMA-617 added to standard care prolonged imaging-based progression-free survival and overall survival
Use of Bronchodilators Down for Bronchiolitis Treatment in Infants
High hospital-level bronchodilator use not associated with better outcomes; adjustment follows AAP recommendations to limit routine use for bronchiolitis
Just 20 States Reached Biden’s July 4 Vaccination Goal
Parts of the South, Southwest, and Midwest starting to see surges, particularly Florida, with about 17 percent of all new cases reported there
Britain to Fully Reopen Soon, Despite Rising COVID-19 Cases
Confirmed COVID-19 cases in Britain have increased, but number of deaths has stayed stable
Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
Factors in therapeutic inertia examined in adults newly diagnosed with T2DM receiving primary care in the U.K.
HIV Incidence Remains Low With PrEP in Real-World Setting
Study of mainly gay or bisexual men shows low incidence of HIV, even when PrEP was mostly purchased rather than provided free
Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients
Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine